CopyFind
Troyplatt 5mg Tablet
medicine 📍 IN

Troyplatt 5mg Tablet

94,95 ₹

Аналоги Troyplatt 5mg Tablet

Знайдіть доступніші аналоги та дженерики для Troyplatt 5mg Tablet.

Інгредієнти

Активний інгредієнт: Prasugrel


Опис товару

About Troyplatt

Troyplatt is a medication containing the active ingredient Prasugrel, classified as Medication used to prevent formation of blood clots. Prasugrel, sold under the brand names Effient and Efient, is a medication used to prevent formation of blood clots. It is a platelet inhibitor and an irreversible antagonist of P2Y12 ADP receptors and is of the thienopyridine drug class. It was developed by Daiichi Sankyo Co.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Prasugrel tablets are a P2Y 12 platelet inhibitor indicated for the reduction of thrombotic cardiovascular events (including.
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Prasugrel, the active ingredient in Troyplatt, belongs to the Medication used to prevent formation of blood clots class. 1 INDICATIONS AND USAGE Prasugrel tablets are a P2Y 12 platelet inhibitor indicated for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with percutaneous coronary intervention (PCI) as follows: Patients with unstable angina. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Troyplatt. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Troyplatt for extended periods without medical advice.

Знайти в аптеках

Порівняйте місцеві ціни та відстань для Troyplatt 5mg Tablet.

Оцінки відвідувачів

Допоможіть іншим — оцініть корисність цієї сторінки.

Оцінок ще немає — будьте першим.